| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 05/18/1995 | WO1995011962A3 Method of controlled genetic transformation of an animal mammary gland and a device for introducing genetic material into the mammary duct of an animal mammary gland |
| 05/18/1995 | DE4326821A1 New cancer vaccine based on autologous, transfected tumour cells |
| 05/18/1995 | CA2176024A1 Therapy |
| 05/18/1995 | CA2173731A1 Neuron-glia cell adhesion molecule, ng-cam, in treatment of nerve damage |
| 05/17/1995 | EP0653635A1 Physiologically active substance fixed sheet, process for its production, method for its storage, and method of supplying physiologically active substance through the sheet |
| 05/17/1995 | EP0653214A1 Topical antibacterial preparation |
| 05/17/1995 | EP0653212A1 Liquid antithrombin iii preparation and method of stabilizing the same |
| 05/17/1995 | EP0653210A1 Intravenous applicable aqueous solution compressing sulfametrol and trimethoprim |
| 05/17/1995 | EP0653205A1 Non-chloroflurocarbon aerosol formulations |
| 05/17/1995 | EP0652967A1 Self-assembling replication defective hybrid virus particles |
| 05/17/1995 | EP0652959A1 Isolation and cloning of a protein with tyrosine-phosphatase activity |
| 05/17/1995 | EP0652896A1 Peptide compounds |
| 05/17/1995 | EP0652776A1 Hepatotropic conjugates of antiviral drugs, carriers thereof and pharmaceutical compositions containing them |
| 05/17/1995 | EP0652775A1 Targeting of liposomes to the blood-brain barrier |
| 05/17/1995 | EP0652774A1 Pharmaceutical composition for topical use containing a crosslinked cationic polymer and an alkoxylated ether. |
| 05/17/1995 | EP0652773A1 The use of nor- and homo- bile acids derivatives as absorption enhancers for medicaments |
| 05/17/1995 | EP0652766A1 Human growth hormone aqueous formulation |
| 05/17/1995 | EP0652758A1 Diphtheria toxin vaccines |
| 05/17/1995 | EP0652757A1 Sugar-free dry mix cellulose ether compositions as bulk laxatives |
| 05/17/1995 | EP0652754A1 Drugs for topical application of sex steroids in the treatment of dry eye syndrome, and methods of preparation and application |
| 05/17/1995 | EP0652752A1 Water-dispersible tablets |
| 05/17/1995 | EP0652749A1 METHODS AND COMPOSITIONS FOR INHIBITING 5$g(a)-REDUCTASE ACTIVITY |
| 05/17/1995 | EP0652746A1 Lymphatic delivery composition |
| 05/17/1995 | EP0567582B1 Liposomal-polyene preliposomal powder and method for its preparation |
| 05/17/1995 | EP0506792B1 Insulin preparations containing nicotinic acid or nicotinamide |
| 05/17/1995 | EP0482185A4 Cell internalizable conjugates and complexes including intracellularly cleavable moieties |
| 05/17/1995 | EP0274482B1 Compositions and methods for clones containing dna sequences associated with multidrug resistance in human cells |
| 05/16/1995 | US5416205 New esters of alginic acid |
| 05/16/1995 | US5416202 Such as gelonin, cysteine substitution |
| 05/16/1995 | US5416078 Parenterally administering deferoxamine and a water soluble biopolymer to a human or animal |
| 05/16/1995 | US5416077 Physical stability improvement of liquid nutritional products |
| 05/16/1995 | US5416075 Water, oil, emulsifiers and amphipatic compound |
| 05/16/1995 | US5416071 Erythropoietin |
| 05/16/1995 | US5416064 Antitumor agents |
| 05/16/1995 | US5416016 Method for enhancing transmembrane transport of exogenous molecules |
| 05/16/1995 | US5415871 Therapeutic agents |
| 05/16/1995 | US5415869 Taxol formulation |
| 05/16/1995 | US5415864 Colonic-targeted oral drug-dosage forms based on crosslinked hydrogels containing azobonds and exhibiting PH-dependent swelling |
| 05/16/1995 | US5415863 Gel contains ethylenediaminetetraacetic acid and carboxypolymethylene; side effect reduction |
| 05/16/1995 | US5415853 Compressed gas packages using polyoxyethylene glyceryl oleates |
| 05/16/1995 | CA2023703C Medical electrical lead with polymeric monolithic controlled release device and method of manufacture |
| 05/16/1995 | CA1335579C Beta-d-glucan, and its production and uses |
| 05/16/1995 | CA1335569C Agents and procedures for provoking an immune response to gnrh and immuno sterilizing mammals |
| 05/12/1995 | CA2135139A1 Topical antibacterial preparation |
| 05/11/1995 | WO1995012629A1 High molecular weight polyesterpolycarbonates and the use thereof for the preparation of bioerosible matrices |
| 05/11/1995 | WO1995012620A1 Derivatized polysaccharide bile acid sequestrant for reducing cholesterol |
| 05/11/1995 | WO1995012414A1 Novel modified pf4 compositions and methods of use |
| 05/11/1995 | WO1995012413A1 Cell control and suppression |
| 05/11/1995 | WO1995012399A1 Composition for drug delivery comprising nicotine or a derivative thereof and starch microspheres and method for the manufacturing thereof |
| 05/11/1995 | WO1995012397A1 Plaster for treating nail mycoses |
| 05/11/1995 | WO1995012393A1 Plaster for the treatment of nail mycoses |
| 05/11/1995 | WO1995012392A1 Biochemically active agents for chemical catalysis and cell receptor activation |
| 05/11/1995 | WO1995012389A1 Multilamellar liposomal arachidonic acid metabolite formulations |
| 05/11/1995 | WO1995012388A1 Methods of treatment using unilamellar liposomal arachidonic acid metabolite formulations |
| 05/11/1995 | WO1995012383A1 An injectable solution of testosterone undecanoate |
| 05/11/1995 | WO1995000638A3 Antisense oligonucleotides and therapeutic use thereof in human immunodeficiency virus infection |
| 05/11/1995 | DE4421686A1 Liposomes containing bioavailable iron(II) and process for their preparation |
| 05/11/1995 | CA2175896A1 Methods of treatment using unilamellar liposomal arachidonic acid metabolite formulations |
| 05/11/1995 | CA2175578A1 Cell control and suppression |
| 05/11/1995 | CA2175057A1 Multilamellar liposomal arachidonic acid metabolite formulations |
| 05/11/1995 | CA2174244A1 Biochemically active agents for chemical catalysis and cell receptor activation |
| 05/10/1995 | EP0652209A1 Derivatives of N-episilon alkoxy-or alkenoxy-carbonyl lysine, their preparation and use in cosmetic, pharmaceutical, hygiene or alimentary compositions |
| 05/10/1995 | EP0652015A2 A sustained release composition comprising a multivalent cation cross-linked algenate combined with a polyacrylic acid |
| 05/10/1995 | EP0651993A1 Percutaneously administrable base composition and drug composition prepared therefrom |
| 05/10/1995 | EP0651799A1 Fibrin binding domain polypeptides and uses and methods of producing same |
| 05/10/1995 | EP0651765A1 Analogs of pth and pthrp, their synthesis and use for the treatment of osteoporosis |
| 05/10/1995 | EP0651740A1 Amino acid linked nitrogen mustard derivatives and their use as prodrugs in the treatment of tumours |
| 05/10/1995 | EP0651646A1 Therapeutic conjugates of toxins and drugs |
| 05/10/1995 | EP0651641A1 Novel bioactive compositions, preparation and use thereof |
| 05/10/1995 | EP0576551B1 Novel encapsulated materials |
| 05/10/1995 | EP0496835B1 Solid tumor treatment method and composition |
| 05/10/1995 | EP0366718B1 Monoclonal antibodies neutralizing hiv-1 |
| 05/10/1995 | CA2135265A1 Stable lyophilized thiotepa composition |
| 05/09/1995 | US5414114 For magnetic resonance imaging |
| 05/09/1995 | US5414077 Non-nucleoside linkers for convenient attachment of labels to oligonucleotides using standard synthetic methods |
| 05/09/1995 | US5414075 Restrained multifunctional reagent for surface modification |
| 05/09/1995 | US5414011 Preservative system for ophthalmic formulations |
| 05/09/1995 | US5413996 Targeted drug delivery via phosphonate derivatives |
| 05/09/1995 | US5413995 Mannitol as excipient |
| 05/09/1995 | US5413914 Yeast assay to identify inhibitors of dibasic amino acid processing endoproteases |
| 05/09/1995 | US5413797 Controlled release ACTH containing microspheres |
| 05/09/1995 | US5413794 Drug delivery |
| 05/09/1995 | US5413793 Treatment of hemorrhoids with drugs in silicone oils and multilayer elements |
| 05/09/1995 | US5413792 Mucoadhesive polysiloxane paste-like base and preparation |
| 05/09/1995 | US5413791 Collagen-polymer conjugates |
| 05/09/1995 | US5413782 Binding pharmaceuticals to ion exchange resins |
| 05/09/1995 | US5413776 Pharmaceutical preparation for percutaneous absorption |
| 05/06/1995 | CA2135123A1 Medicine for preventing and curing bone fracture |
| 05/04/1995 | WO1995011988A1 Compounds with pth activity and recombinant dna vectors encoding same |
| 05/04/1995 | WO1995011977A2 A NEW RIBOSOME-INACTIVATING PROTEIN ISOLATED FROM THE PLANT $i(BRYONIA DIOICA) |
| 05/04/1995 | WO1995011962A2 Method of controlled genetic transformation of an animal mammary gland and a device for introducing genetic material into the mammary duct of an animal mammary gland |
| 05/04/1995 | WO1995011924A1 Non-antigenic branched polymer conjugates |
| 05/04/1995 | WO1995011704A1 Liposome having oligosaccharide on the surface |
| 05/04/1995 | WO1995011703A1 Nitrophenyl derivatives that can be activated by light |
| 05/04/1995 | WO1995011694A1 Compositions that specifically bind to colorectal cancer cells and methods of using the same |
| 05/04/1995 | WO1995011690A1 Desferrioxamine oral delivery system |
| 05/04/1995 | WO1995011683A1 Stabilized prostaglandin e¿1? |
| 05/04/1995 | WO1995011677A1 A stable pharmaceutical composition of terfenadine and ibuprofen |
| 05/04/1995 | WO1995011676A1 Long-acting antifungal o/w preparation |
| 05/04/1995 | WO1995011674A1 Granular preparation |